Preclinical Excellence for Safer, Smarter Medical Innovations
At HuaTeng Biotechnology, we specialize in GLP-compliant in vivo testing for medical devices, delivering robust preclinical data to accelerate regulatory approvals (FDA, CE, NMPA) and ensure patient safety. Our advanced animal models, state-of-the-art facilities, and ISO 10993-aligned protocols empower innovators to validate device performance, biocompatibility, and long-term efficacy with confidence.
Stent patency, heart valve durability (porcine models).
Bone integration, wear resistance (rabbit, sheep).
Electrode biocompatibility (rodent, NHP).
Coated stents, insulin pumps (diabetic minipigs).
Replicate human anatomy for device deployment practice.
Hands-on workshops using our animal facilities.
HuaTeng Biotechnology provides GLP-compliant large animal models to support comprehensive medical device validation. Our studies generate scientifically rigorous preclinical data, helping to de-risk regulatory pathways and accelerate global approvals. We bring deep expertise across orthopaedic, cardiovascular, dental, and active implant studies, with strong emphasis on species-specific physiological relevance and translational study design.
Learn MoreGlobal Compliance: AAALAC-accredited facilities with IACUC oversight, aligned with EU Directive 2010/63/EU and USDA standards—ensuring full regulatory acceptance across major markets.
Advanced Imaging Capabilities: Integrated platforms including DSA, IVUS, angiography and micro-CT, enabling real-time evaluation of device performance and in vivo outcomes.
Custom Model Development: Species-specific animal models tailored to complex disease conditions, improving translational relevance and clinical predictability.
Integrated Histopathology Suite: SEM and TEM analysis supported by GLP-grade reporting, enabling seamless submission to PMDA, CE Mark and global regulatory authorities.